Heimdall Insights

Global Humira Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Humira Market was valued at $9.6 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.1% CAGR, to an estimated market size of $12.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Humira market encompasses the commercial sales and therapeutic application of the biologic drug adalimumab, including the original branded product and its biosimilar competitors. The scope covers treatments for autoimmune and inflammatory conditions such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis, while excluding non-adalimumab TNF inhibitors.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Humira Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Branded Humira (Originator)
  • Adalimumab Biosimilars